Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model
- 25 April 2002
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (9) , 584-591
- https://doi.org/10.1038/sj.gt.3301693
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immune escape of gliomasPublished by Elsevier ,2001
- In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirusCancer Gene Therapy, 2000
- A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapyHuman Gene Therapy, 1998
- Double Suicide Gene (Cytosine Deaminase and Herpes Simplex Virus Thymidine Kinase) but Not Single Gene Transfer Allows Reliable Elimination of Tumor CellsIn VivoHuman Gene Therapy, 1998
- Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene TherapiesJNCI Journal of the National Cancer Institute, 1998
- Glioma Cells Transduced with anEscherichia coliCD/HSV-1 TK Fusion Gene Exhibit Enhanced Metabolic Suicide and RadiosensitivityHuman Gene Therapy, 1997
- Results of Three Consecutive Combined Treatments for Malignant GliomasAmerican Journal of Clinical Oncology, 1994
- Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.Proceedings of the National Academy of Sciences, 1992
- Treatment of gliomas in adultsCurrent Opinion in Oncology, 1991
- National survey of patterns of care for brain-tumor patientsJournal of Neurosurgery, 1989